학술논문
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity.
Document Type
Article
Author
Source
Subject
*POLYMERSOMES
*INTERFERON receptors
*BIOENGINEERING
*BONE marrow cells
*OVALBUMINS
*CYTOTOXIC T cells
*TUMOR antigens
*KILLER cells
*
*
*
*
*
*
*
Language
ISSN
2375-2548
Abstract
The article reports that Mounting evidence suggests that immunotherapies are a promising new class of anticancer therapies. However, the immunosuppressive tumor microenvironment (TME), poor immunogenicity, and off-target toxicity hinder the broader implementation of immunotherapies. It mentions effective immunotherapy combination regimen to convert uninflamed "cold" tumors into "hot" tumors, addressing the major challenges immunotherapies faced.